CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
SWEATPATCH develops a non-invasive method to monitor breast cancer treatment response in real-time using volatile organic compounds from sweat. This innovative technology employs advanced materials and sensors to provide personalized insights into tumor biology, enhancing precision oncology.
Breast Cancer (BC) is the most common cancer in Europe.
In most cases, BC will present at a locally advanced or distant stage, which requiresanticancer drugs.
However, there is no guarantee that the favorable drug benefit/risk balance will align with expectations at an individual level or be maintained over time.
Therefore, monitoring tumor response to treatment is critical for timely adjusting the therapeutic strategy to improve patients’ outcomes.
To fulfill this unmet medical need,SWEATPATCH…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Valencia
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Bordeaux
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Talence
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
